{
    "organizations": [],
    "uuid": "ca72cb43df2bb9fd677dfa1099376906b4097660",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-aclaris-therapeutics-names-bryan-r/brief-aclaris-therapeutics-names-bryan-reasons-director-and-chairman-audit-committee-idUSASC09X4I",
    "ord_in_thread": 0,
    "title": "BRIEF-Aclaris Therapeutics Names Bryan Reasons Director And Chairman, Audit Committee",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " Aclaris Therapeutics Inc:\n* ACLARIS THERAPEUTICS ANNOUNCES APPOINTMENT OF BRYAN REASONS AS A DIRECTOR AND CHAIRMAN OF THE AUDIT COMMITTEE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-25T04:54:00.000+03:00",
    "crawled": "2018-04-25T14:12:38.031+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "aclaris",
        "therapeutic",
        "inc",
        "aclaris",
        "therapeutic",
        "announces",
        "appointment",
        "bryan",
        "reason",
        "director",
        "chairman",
        "audit",
        "committee",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}